Track Tango Therapeutics's current cash ($160M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Tango Therapeutics (TNGX) currently reports a current cash of $160M as of March 2026. That compares with $58M in the prior-year period — up 170.1% year over year. Use the charts on this page to explore Tango Therapeutics's current cash history and peer comparisons.
Tango Therapeutics's current cash increased from $58M to $160M — a 170.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Tango Therapeutics reported $160M in current cash as of March 2026. That compares with $58M in the prior-year period — up 170.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tango Therapeutics, and consider following TNGX for alerts when major investors trade the stock.
Tango Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $160M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TNGX with unrelated industries.